Back to Search
CESAR ALBARRACIN, MD
MD
Internal Medicine Physician
NPI: 1457331456IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
K3967(TX)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 1980
Research & Publications (20)
Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial.
PMID 17684468·J Cardiometab Syndr·2007
2-rct
The role of hMSH3 and hMSH6 in ovarian endometrioid carcinoma and relationship with microsatellite instability phenotype.
PMID 15547740·Oncol Rep·2004
8-other
Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years' of experience at a single institution.
PMID 18626769·Breast Cancer Res Treat·2011
8-other
High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.
PMID 19174581·Cancer Prev Res (Phila)·2009
8-other
Survival among women with triple receptor-negative breast cancer and brain metastases.
PMID 19150943·Ann Oncol·2009
8-other
MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.
PMID 19342367·Am J Pathol·2009
8-other
Ductal carcinoma in situ: state of the science and roadmap to advance the field.
PMID 19064970·J Clin Oncol·2009
6-review
Matrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma.
PMID 19047898·Am J Surg Pathol·2009
8-other
Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
PMID 19047281·J Clin Oncol·2009
8-other
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
PMID 19596702·Ann Oncol·2009
8-other
Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases.
PMID 18084246·Mod Pathol·2008
8-other
Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
PMID 18779615·J Clin Oncol·2008
8-other
Loss of annexin A1 expression in breast cancer progression.
PMID 18776816·Appl Immunohistochem Mol Morphol·2008
8-other
MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
PMID 18663355·Oncogene·2008
8-other
Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
PMID 18300793·Am J Surg Pathol·2008
4-observational
Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers.
PMID 18176935·Mol Carcinog·2008
8-other
Development of new cancers in patients with DCIS: the M.D. Anderson experience.
PMID 18043978·Ann Surg Oncol·2008
8-other
Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma.
PMID 18091390·Appl Immunohistochem Mol Morphol·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 N BISHOP AVE STE 2
DALLAS, TX 75208 - Phone
- (214) 941-0801
Quick Facts
- NPI
- 1457331456
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile